Ironwood Pharmaceuticals Stock Price on December 18, 2024
| IRWD Stock | USD 4.61 0.02 0.44% |
Below is the normalized historical share price chart for Ironwood Pharmaceuticals extending back to February 03, 2010. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Ironwood Pharmaceuticals stands at 4.61, as last reported on the 26th of December, with the highest price reaching 4.70 and the lowest price hitting 4.56 during the day.
If you're considering investing in Ironwood Stock, it is important to understand the factors that can impact its price. Ironwood Pharmaceuticals appears to be moderately volatile, given 3 months investment horizon. Ironwood Pharmaceuticals holds Efficiency (Sharpe) Ratio of 0.0669, which attests that the entity had a 0.0669% return per unit of risk over the last 3 months. We have found thirty technical indicators for Ironwood Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please utilize Ironwood Pharmaceuticals' Risk Adjusted Performance of 0.0571, market risk adjusted performance of 0.1253, and Downside Deviation of 4.14 to validate if our risk estimates are consistent with your expectations.
At present, Ironwood Pharmaceuticals' Sale Purchase Of Stock is projected to decrease significantly based on the last few years of reporting. . At present, Ironwood Pharmaceuticals' Price To Operating Cash Flows Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Cash Flow Ratio is expected to grow to 10.18, whereas Price Earnings Ratio is forecasted to decline to (1.86). Ironwood Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 3rd of February 2010 | 200 Day MA 5.7254 | 50 Day MA 3.9974 | Beta 0.475 |
Ironwood |
Sharpe Ratio = 0.0669
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | IRWD | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.12 actual daily | 45 55% of assets are more volatile |
Expected Return
| 0.34 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Ironwood Pharmaceuticals is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ironwood Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 2.5899 | Enterprise Value Ebitda 11.9092 | Price Sales 1.9495 | Shares Float 132.2 M | Wall Street Target Price 12.5 |
Related Headline
Pacira BioSciences, Headline on 18th of December 2024
Heres Why Pacira is a Strong Momentum Stock by finance.yahoo.com
Whether youre a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Ironwood Pharmaceuticals Valuation on December 18, 2024
It is possible to determine the worth of Ironwood Pharmaceuticals on a given historical date. On December 18, 2024 Ironwood was worth 3.56 at the beginning of the trading date compared to the closed value of 3.46. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Ironwood Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Ironwood Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Ironwood Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Ironwood Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 3.38 | 3.65 | 3.38 | 3.53 | 2,369,738 | |
12/18/2024 | 3.56 | 3.69 | 3.41 | 3.46 | 2,534,998 |
| 3.46 | 3.93 | 3.37 | 3.88 | 3,930,836 |
| Backtest Ironwood Pharmaceuticals | | | Ironwood Pharmaceuticals History | | | Ironwood Pharmaceuticals Valuation | Previous | Next |
Ironwood Pharmaceuticals Trading Date Momentum on December 18, 2024
| On December 19 2024 Ironwood Pharmaceuticals was traded for 3.88 at the closing time. The top price for the day was 3.93 and the lowest listed price was 3.37 . The trading volume for the day was 3.9 M. The trading history from December 19, 2024 was a factor to the next trading day price growth. The trading delta at closing time against the next closing price was 12.14% . The trading delta at closing time against the current closing price is 33.82% . |
Ironwood Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Ironwood Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Ironwood Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Ironwood financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Ironwood Pharmaceuticals Stock history
Ironwood Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Ironwood is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Ironwood Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Ironwood Pharmaceuticals stock prices may prove useful in developing a viable investing in Ironwood Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 155.4 M | 137.1 M | |
| Net Income Applicable To Common Shares | 201.3 M | 211.4 M |
Ironwood Pharmaceuticals Stock Technical Analysis
Ironwood Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Ironwood Pharmaceuticals Period Price Range
Low | December 26, 2024
| High |
0.00 | 0.00 |
Ironwood Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Ironwood Pharmaceuticals December 26, 2024 Market Strength
Market strength indicators help investors to evaluate how Ironwood Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Ironwood Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Ironwood Pharmaceuticals stock market strength indicators, traders can identify Ironwood Pharmaceuticals entry and exit signals to maximize returns
Ironwood Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Ironwood Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Ironwood Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Ironwood to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0571 | |||
| Jensen Alpha | 0.2069 | |||
| Total Risk Alpha | 0.0775 | |||
| Sortino Ratio | 0.0631 | |||
| Treynor Ratio | 0.1153 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Ironwood Stock analysis
When running Ironwood Pharmaceuticals' price analysis, check to measure Ironwood Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ironwood Pharmaceuticals is operating at the current time. Most of Ironwood Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Ironwood Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ironwood Pharmaceuticals' price. Additionally, you may evaluate how the addition of Ironwood Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |